Holly Sheffield Acquires 1,230 Shares of Cooper Companies (NASDAQ:COO) Stock

The Cooper Companies, Inc. (NASDAQ:COO) insider Holly Sheffield purchased 1,230 shares of the company’s stock in a transaction dated Tuesday, December 16th. The shares were bought at an average price of $80.75 per share, for a total transaction of $99,322.50. Following the completion of the transaction, the insider directly owned 39,052 shares in the company, valued at approximately $3,153,449. This trade represents a 3.25% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Cooper Companies Stock Performance

COO traded down $0.49 during trading on Tuesday, reaching $81.04. 2,057,390 shares of the company were exchanged, compared to its average volume of 2,465,645. The Cooper Companies, Inc. has a 52 week low of $61.78 and a 52 week high of $100.24. The company has a current ratio of 1.89, a quick ratio of 1.13 and a debt-to-equity ratio of 0.30. The firm has a 50 day moving average of $73.67 and a 200 day moving average of $71.65. The stock has a market cap of $15.88 billion, a P/E ratio of 43.11, a PEG ratio of 2.34 and a beta of 1.05.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, December 4th. The medical device company reported $1.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.04. Cooper Companies had a net margin of 9.16% and a return on equity of 10.02%. The company had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.06 billion. During the same quarter in the previous year, the company posted $1.04 earnings per share. The company’s revenue for the quarter was up 4.6% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. On average, sell-side analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies declared that its Board of Directors has initiated a share repurchase program on Wednesday, September 17th that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the medical device company to repurchase up to 15.4% of its shares through open market purchases. Shares repurchase programs are generally a sign that the company’s board of directors believes its stock is undervalued.

Hedge Funds Weigh In On Cooper Companies

Large investors have recently made changes to their positions in the business. Bell Investment Advisors Inc raised its holdings in shares of Cooper Companies by 106.3% in the 3rd quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock worth $29,000 after purchasing an additional 219 shares in the last quarter. J.Safra Asset Management Corp boosted its holdings in Cooper Companies by 204.8% during the second quarter. J.Safra Asset Management Corp now owns 506 shares of the medical device company’s stock worth $36,000 after buying an additional 340 shares in the last quarter. CYBER HORNET ETFs LLC acquired a new position in Cooper Companies in the second quarter worth approximately $36,000. GKV Capital Management Co. Inc. bought a new position in shares of Cooper Companies in the first quarter valued at $40,000. Finally, MUFG Securities EMEA plc bought a new position in shares of Cooper Companies in the second quarter valued at $42,000. Institutional investors own 24.39% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on COO. Piper Sandler reissued an “overweight” rating and issued a $94.00 price target (up previously from $83.00) on shares of Cooper Companies in a research note on Friday, December 5th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Cooper Companies in a research report on Monday. Barclays reissued an “overweight” rating and set a $91.00 target price on shares of Cooper Companies in a research note on Monday, December 8th. The Goldman Sachs Group reaffirmed a “sell” rating and issued a $71.00 price target (up from $64.00) on shares of Cooper Companies in a research note on Monday, December 8th. Finally, Stifel Nicolaus set a $95.00 price objective on shares of Cooper Companies and gave the company a “buy” rating in a research note on Friday, December 5th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, five have given a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, Cooper Companies currently has a consensus rating of “Moderate Buy” and a consensus target price of $90.15.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.